Cited by 229Wound Healing and TreatmentsNonmelanoma Skin Cancer StudiesMacrophage Migration Inhibitory Factor

Gene expression profiling of cutaneous wound healing

Open access
Deonarine, Kavita, Panelli, Monica C, Stashower, Mitchell E, Jin, Ping, Smith, Kina, Slade, Herbert B, Norwood, Christopher, Wang, Ena +2 more·2007·Journal of Translational Medicine

Abstract

Background: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex progression of events. Study Design: This study was part of a placebo-controlled double-blind clinical trial in which basal cell carcinomas were treated topically with an immunomodifier – toll-like receptor 7 agonist: imiquimod. The fourteen patients with basal cell carcinoma in the placebo arm of the trial received placebo treatment consisting solely of vehicle cream. A skin punch biopsy was obtained immediately before treatment and at the end of the placebo treatment (after 2, 4 or 8 days). 17.5K cDNA microarrays were utilized to profile the biopsy material. Results: Four gene signatures whose expression changed relative to baseline (before wound induction by the pre-treatment biopsy) were identified. The largest group was comprised predominantly of inflammatory genes whose expression was increased throughout the study. Two additional signatures were observed which included preferentially pro-inflammatory genes in the early post-treatment biopsies (2 days after pre-treatment biopsies) and repair and angiogenesis genes in the later (4 to 8 days) biopsies. The fourth and smallest set of genes was down-regulated throughout the study. Early in wound healing the expression of markers of both M1 and M2 macrophages were increased, but later M2 markers predominated. Conclusion: The initial response to a cutaneous wound induces powerful transcriptional activation of pro-inflammatory stimuli which may alert the host defense. Subsequently and in the absence of infection, inflammation subsides and it is replaced by angiogenesis and remodeling. Understanding this transition which may be driven by a change from a mixed macrophage population to predominately M2 macrophages, may help the interpretation of the cellular and molecular events occurring in the microenvironment of serially biopsied tissues.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1479-5876-5-11

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Regenerative properties of microglia/macrophages following injury to muscle and skin are associated with alternative or deactivation to M2-polarized phenotypes (M2a and M2c, respectively).

    “Regenerative properties of microglia/macrophages following injury to muscle6, 7 and skin8 are associated with alternative or deactivation to M2-polarized phenotypes (M2a and M2c, respectively), which secrete anti-inflammatory cytokines/growth factors9.”

    From M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination (2013) · cites this paper as [8]

    For the skin-injury portion cited to this paper, the Results (Comparison of markers of M1 and M2 macrophages; page not provided) report predominantly M2 markers later in cutaneous wound healing. The Discussion links M2 macrophages to tissue repair and angiogenesis, but does not identify the skin-associated phenotype as M2c or establish that a shift to M2 causes regeneration. The muscle-injury citations are separate from this source. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • A switch from M1- to M2-associated gene expression has been reported during cutaneous wound healing but has not been observed in studies of immune-mediated and toxin (cuprizone)-induced demyelination.

    “A switch from M1- to M2-associated gene expression has been reported during cutaneous wound healing8 but has not been observed in studies of immune-mediated36 and toxin (cuprizone)-induced demyelination37.”
  • In a study of human cutaneous wound healing, two gene clusters associated with M1/M2 polarization were transiently upregulated: an early cluster with mixed M1 and M2 genes (11 M1, 7 M2) and a later cluster predominantly M2 (1 M1, 9 M2).

    “Of note, however, investigators identified two clusters of genes, associated with macrophage M1/ M2 polarization, which were upregulated transiently during the wound healing process.”
  • Treatment of rats, mice, and pigs with GHK effectively activates systemic healing throughout the animal.

    “The treatment of rats, mice, and pigs with GHK was shown to effectively activate systemic healing throughout the animal.”

    From GHK and DNA: Resetting the human genome to health (2014) · cites this paper as [40]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Deonarine, K., Panelli, M. C., Stashower, M. E., Jin, P., Smith, K., Slade, H. B., Norwood, C., Wang, E., Marincola, F. M., & Stroncek, D. F.
Affiliations
National Institutes of Health (US)
Corresponding author
Stroncek, David F
Venue
Journal of Translational Medicine
Published
2007-02-21
Volume
5
Issue
1
Pages
11-11
ISSN
1479-5876 (ISSN-L)
OpenAlex
W1594905954
Cited by
229
References
29
Citations by year
2025: 6 · 2024: 6 · 2023: 9 · 2022: 30 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 10 · 2017: 10 · 2016: 16 · 2015: 17 · 2014: 19 · 2013: 23 · 2012: 18
FWCI
10.46
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Epidemiology › Nonmelanoma Skin Cancer Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
Keywords
skin wound healing, basal cell carcinoma, imiquimod, Toll-like receptor 7 agonist, gene expression profiling, inflammatory gene signature, M1/M2 macrophages, angiogenesis, tissue remodeling, skin biopsy, topical immunotherapy
MeSH terms
Imiquimod, Administration, Topical, Aminoquinolines, Biopsy, Humans, Macrophages, Placebos, Skin, Wound Healing, Biomarkers, Gene Expression Regulation, Neoplastic, Cluster Analysis, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review